A case of large-cell neuroendocrine carcinoma harboring an EML4-ALK rearrangement with resistance to the ALK inhibitor crizotinib.
暂无分享,去创建一个
M. Kitaichi | S. Shimizu | K. Asami | T. Kawaguchi | A. Tamiya | S. Atagi | M. Kanazu | K. Okishio | K. Tezuka | N. Omachi